Vanguard Group Inc

Holdings History for Niagen Bioscience, Inc. - Common Stock (NAGE)

Symbol: NAGE on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 4.02M shares
Security Ownership: 5.04%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in Niagen Bioscience, Inc. Common Stock (NAGE)

2025-10-31 - The Vanguard Group has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.02M shares of Niagen Bioscience, Inc. Common Stock (NAGE). This represents 5.04% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	5.04%		$37.5M	4.02M			$9.33	13G	9/30/2025	31 Oct 2025 11:03:02

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0%	+0%	$37.5M	4.02M	+97,083	+2.47%	$9.33	Q3 2025
6/30/2025	0%	+0%	$56.6M	3.92M	+383,904	+10.8%	$14.41	Q2 2025
3/31/2025	0%	+0%	$24.4M	3.54M	+151,116		$6.90	Q1 2025
12/31/2024	0%	0%	$18M	3.39M	-40,809	-1.19%	$5.31	Q4 2024
9/30/2024	0%	+0%	$12.5M	3.43M	+43,931	+1.3%	$3.65	Q3 2024
6/30/2024	0%	+0%	$9.24M	3.39M	+338,306	+11.1%	$2.73	Q2 2024
3/31/2024	0%		$10.6M	3.05M			$3.48	Q1 2024
12/31/2023	0%		$4.36M	3.05M	+4,477	+0.15%	$1.43	Q4 2023
9/30/2023	0%		$4.44M	3.04M			$1.46	Q3 2023
6/30/2023	0%	0%	$4.78M	3.04M	-84,376	-2.7%	$1.57	Q2 2023
3/31/2023	0%	+0%	$4.79M	3.13M	+518,823	+19.9%	$1.53	Q1 2023
12/31/2022	0%	+0%	$4.38M	2.61M	+377,898	+16.9%	$1.68	Q4 2022
9/30/2022	0%	+0%	$2.74M	2.23M	+48,853	+2.24%	$1.23	Q3 2022
6/30/2022	0%	0%	$3.65M	2.18M	-598,993	-21.5%	$1.67	Q2 2022
3/31/2022	0%	+0%	$6.84M	2.78M	+240,414	+9.46%	$2.46	Q1 2022
12/31/2021	0%	0%	$9.5M	2.54M	-90,550	-3.44%	$3.74	Q4 2021
9/30/2021	0%	+0%	$16.5M	2.63M	+22,936	+0.88%	$6.27	Q3 2021
6/30/2021	0%	+0%	$25.7M	2.61M	+266,299	+11.4%	$9.86	Q2 2021
3/31/2021	0%	0%	$21.9M	2.34M	-96,218	-3.95%	$9.34	Q1 2021
12/31/2020	0%	0%	$11.7M	2.44M	-22,929	-0.93%	$4.80	Q4 2020
9/30/2020	0%	+0%	$9.87M	2.46M	+203,829	+9.03%	$4.01^*	Q3 2020
6/30/2020	0%	+0%	$10.4M	2.26M	+52,290	+2.37%	$4.59	Q2 2020
3/31/2020	0%	+0%	$7.19M	2.21M	+116,556	+5.58%	$3.26^*	Q1 2020
12/31/2019	0%	+0%	$9M	2.09M	+200,908	+10.6%	$4.31	Q4 2019
9/30/2019	0%	+0%	$7.43M	1.89M	+127,069	+7.22%	$3.94	Q3 2019
6/30/2019	0%		$8.19M	1.76M	+700	+0.04%	$4.65	Q2 2019
3/31/2019	0%	+0%	$7.38M	1.76M	+165,618	+10.4%	$4.19	Q1 2019
12/31/2018	0%	+0%	$5.47M	1.59M	+22,437	+1.43%	$3.43	Q4 2018
9/30/2018	0%	+0%	$6.74M	1.57M	+88,125	+5.94%	$4.29	Q3 2018
6/30/2018	0%	+0%	$5.51M	1.48M	+242,131	+19.5%	$3.71	Q2 2018
3/31/2018	0%	+0%	$5.22M	1.24M	+232,771	+23.1%	$4.20	Q1 2018
12/31/2017	0%	+0%	$5.93M	1.01M	+30,061	+3.07%	$5.88	Q4 2017
9/30/2017	0%	+0%	$4.21M	979K	+85,049	+9.51%	$4.30	Q3 2017
6/30/2017	0%	0%	$3.42M	894K	-91,331	-9.27%	$3.82	Q2 2017
3/31/2017	0%	+0%	$2.65M	985K	+39,052	+4.13%	$2.69	Q1 2017
12/31/2016	0%	+0%	$3.13M	946K	+9,957	+1.06%	$3.31	Q4 2016
9/30/2016	0%	+0%	$2.79M	936K	+32,011	+3.54%	$2.98	Q3 2016
6/30/2016	0%	+0%	$3.74M	904K	+904,252	NEW	$4.14	Q2 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.